3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Neuroblastoma
10
Melanoma
8
Neoplasm Metastasis
6
Breast Neoplasms
6
Ganglioneuroblastoma
5
Triple Negative Breast Neoplasms
4
Prostatic Neoplasms
4
Multiple Myeloma
4
Lymphoma
4
Lung Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Myelodysplastic Syndromes
3
Lymphoma, Non-Hodgkin
3
Leukemia, Myeloid, Acute
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Glioblastoma
3
Carcinoma, Renal Cell
3
Brain Neoplasms
3
Uveal Melanoma
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Oligodendroglioma
2
Neoplasms
2
Medulloblastoma
2
Lymphoma, Follicular
2
Leukemia
2
Gliosarcoma
2
Glioma
2
Carcinoma, Intraductal, Noninfiltrating
2
Astrocytoma
2
Interventions
Cisplatin
274
pembrolizumab
229
Radiotherapy
166
Cetuximab
163
Carboplatin
122
Docetaxel
109
Paclitaxel
94
Fluorouracil
94
Nivolumab
84
Radiotherapy, Intensity-Modulated
78
Magnetic Resonance Spectroscopy
39
durvalumab
35
Radiation
32
Surgical Procedures, Operative
31
Drug Therapy
30
Radiosurgery
25
Erlotinib Hydrochloride
25
Biopsy
25
Albumin-Bound Paclitaxel
24
130-nm albumin-bound paclitaxel
24
Taxes
23
Platinum
22
Specimen Handling
21
tislelizumab
20
1,2-diaminocyclohexaneplatinum II citrate
20
Cyclophosphamide
19
Capecitabine
19
tremelimumab
18
Ipilimumab
18
Gemcitabine
18
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Squamous Cell Carcinoma of Head and Neck
×
Colony-Stimulating Factors
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled